Catabolic effects of muramyl dipeptide on rabbit chondrocytes

Tetsuro Ikebe, Hideaki Iribe, Masato Hirata, Fumi Yanaga, Toshitaka Koga

研究成果: ジャーナルへの寄稿記事

2 引用 (Scopus)

抄録

Muramyl dipeptide, an essential structure for the diverse biologic activities of bacterial cell wall peptidoglycan, inhibited the synthesis of glycosaminoglycan/proteoglycan in cultured rabbit costal chondrocytes in a dose‐dependent manner. Muramyl dipeptide, as well as lipopolysaccharide and interleukin‐1α, also enhanced the release of 35S‐sulfate—prelabeled glycosaminoglycan/proteoglycan from the cell layer, which seems to reflect, at least partially, the increasing degradation of glycosaminoglycan/proteoglycan. Five synthetic analogs of muramyl dipeptide known to be adjuvant active or adjuvant inactive were tested for their potential to inhibit synthesis of glycosaminoglycan/proteoglycan and to enhance the release of glycosaminoglycan/proteoglycan in chondrocytes. The structural dependence of these synthetic analogs on chondrocytes was found to parallel that of immunoadjuvant activity. These results suggest that muramyl dipeptide is a potent mediator of catabolism in chondrocytes.

元の言語英語
ページ(範囲)1801-1806
ページ数6
ジャーナルArthritis and Rheumatism
33
発行部数12
DOI
出版物ステータス出版済み - 1990

Fingerprint

Acetylmuramyl-Alanyl-Isoglutamine
Proteoglycans
Chondrocytes
Glycosaminoglycans
Rabbits
Immunologic Adjuvants
Peptidoglycan
Cell Wall
Lipopolysaccharides

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Pharmacology (medical)

これを引用

Ikebe, T., Iribe, H., Hirata, M., Yanaga, F., & Koga, T. (1990). Catabolic effects of muramyl dipeptide on rabbit chondrocytes. Arthritis and Rheumatism, 33(12), 1801-1806. https://doi.org/10.1002/art.1780331207

Catabolic effects of muramyl dipeptide on rabbit chondrocytes. / Ikebe, Tetsuro; Iribe, Hideaki; Hirata, Masato; Yanaga, Fumi; Koga, Toshitaka.

:: Arthritis and Rheumatism, 巻 33, 番号 12, 1990, p. 1801-1806.

研究成果: ジャーナルへの寄稿記事

Ikebe, T, Iribe, H, Hirata, M, Yanaga, F & Koga, T 1990, 'Catabolic effects of muramyl dipeptide on rabbit chondrocytes', Arthritis and Rheumatism, 巻. 33, 番号 12, pp. 1801-1806. https://doi.org/10.1002/art.1780331207
Ikebe, Tetsuro ; Iribe, Hideaki ; Hirata, Masato ; Yanaga, Fumi ; Koga, Toshitaka. / Catabolic effects of muramyl dipeptide on rabbit chondrocytes. :: Arthritis and Rheumatism. 1990 ; 巻 33, 番号 12. pp. 1801-1806.
@article{7e6266b98405415f88e7e55425a4313a,
title = "Catabolic effects of muramyl dipeptide on rabbit chondrocytes",
abstract = "Muramyl dipeptide, an essential structure for the diverse biologic activities of bacterial cell wall peptidoglycan, inhibited the synthesis of glycosaminoglycan/proteoglycan in cultured rabbit costal chondrocytes in a dose‐dependent manner. Muramyl dipeptide, as well as lipopolysaccharide and interleukin‐1α, also enhanced the release of 35S‐sulfate—prelabeled glycosaminoglycan/proteoglycan from the cell layer, which seems to reflect, at least partially, the increasing degradation of glycosaminoglycan/proteoglycan. Five synthetic analogs of muramyl dipeptide known to be adjuvant active or adjuvant inactive were tested for their potential to inhibit synthesis of glycosaminoglycan/proteoglycan and to enhance the release of glycosaminoglycan/proteoglycan in chondrocytes. The structural dependence of these synthetic analogs on chondrocytes was found to parallel that of immunoadjuvant activity. These results suggest that muramyl dipeptide is a potent mediator of catabolism in chondrocytes.",
author = "Tetsuro Ikebe and Hideaki Iribe and Masato Hirata and Fumi Yanaga and Toshitaka Koga",
year = "1990",
doi = "10.1002/art.1780331207",
language = "English",
volume = "33",
pages = "1801--1806",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "12",

}

TY - JOUR

T1 - Catabolic effects of muramyl dipeptide on rabbit chondrocytes

AU - Ikebe, Tetsuro

AU - Iribe, Hideaki

AU - Hirata, Masato

AU - Yanaga, Fumi

AU - Koga, Toshitaka

PY - 1990

Y1 - 1990

N2 - Muramyl dipeptide, an essential structure for the diverse biologic activities of bacterial cell wall peptidoglycan, inhibited the synthesis of glycosaminoglycan/proteoglycan in cultured rabbit costal chondrocytes in a dose‐dependent manner. Muramyl dipeptide, as well as lipopolysaccharide and interleukin‐1α, also enhanced the release of 35S‐sulfate—prelabeled glycosaminoglycan/proteoglycan from the cell layer, which seems to reflect, at least partially, the increasing degradation of glycosaminoglycan/proteoglycan. Five synthetic analogs of muramyl dipeptide known to be adjuvant active or adjuvant inactive were tested for their potential to inhibit synthesis of glycosaminoglycan/proteoglycan and to enhance the release of glycosaminoglycan/proteoglycan in chondrocytes. The structural dependence of these synthetic analogs on chondrocytes was found to parallel that of immunoadjuvant activity. These results suggest that muramyl dipeptide is a potent mediator of catabolism in chondrocytes.

AB - Muramyl dipeptide, an essential structure for the diverse biologic activities of bacterial cell wall peptidoglycan, inhibited the synthesis of glycosaminoglycan/proteoglycan in cultured rabbit costal chondrocytes in a dose‐dependent manner. Muramyl dipeptide, as well as lipopolysaccharide and interleukin‐1α, also enhanced the release of 35S‐sulfate—prelabeled glycosaminoglycan/proteoglycan from the cell layer, which seems to reflect, at least partially, the increasing degradation of glycosaminoglycan/proteoglycan. Five synthetic analogs of muramyl dipeptide known to be adjuvant active or adjuvant inactive were tested for their potential to inhibit synthesis of glycosaminoglycan/proteoglycan and to enhance the release of glycosaminoglycan/proteoglycan in chondrocytes. The structural dependence of these synthetic analogs on chondrocytes was found to parallel that of immunoadjuvant activity. These results suggest that muramyl dipeptide is a potent mediator of catabolism in chondrocytes.

UR - http://www.scopus.com/inward/record.url?scp=0025681649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025681649&partnerID=8YFLogxK

U2 - 10.1002/art.1780331207

DO - 10.1002/art.1780331207

M3 - Article

VL - 33

SP - 1801

EP - 1806

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 12

ER -